These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 22315210
1. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension. Hollatz TJ, Musat A, Westphal S, Decker C, D'Alessandro AM, Keevil J, Zhanhai L, Runo JR. Liver Transpl; 2012 Jun; 18(6):686-95. PubMed ID: 22315210 [Abstract] [Full Text] [Related]
2. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W. Wien Klin Wochenschr; 2000 Jul 28; 112(14):637-40. PubMed ID: 11008327 [Abstract] [Full Text] [Related]
3. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Fix OK, Bass NM, De Marco T, Merriman RB. Liver Transpl; 2007 Jun 28; 13(6):875-85. PubMed ID: 17539008 [Abstract] [Full Text] [Related]
4. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS. J Heart Lung Transplant; 2007 Nov 28; 26(11):1079-83. PubMed ID: 18022071 [Abstract] [Full Text] [Related]
5. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation. Raevens S, De Pauw M, Reyntjens K, Geerts A, Verhelst X, Berrevoet F, Rogiers X, Troisi RI, Van Vlierberghe H, Colle I. Eur J Gastroenterol Hepatol; 2013 Apr 28; 25(4):495-502. PubMed ID: 23242127 [Abstract] [Full Text] [Related]
6. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]. Jiménez López-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jiménez JF, Sadia Pérez D, Velázquez Martín MT, Gómez Sánchez MA, Sáenz de la Calzada C. Rev Esp Cardiol; 2004 Oct 28; 57(10):946-51. PubMed ID: 15469792 [Abstract] [Full Text] [Related]
11. Portopulmonary hypertension: short review. Stauber RE, Olschewski H. Eur J Gastroenterol Hepatol; 2010 Apr 28; 22(4):385-90. PubMed ID: 19907338 [Abstract] [Full Text] [Related]
12. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension. Sağ S, Yeşilbursa D, Güllülü S. Turk J Gastroenterol; 2014 Aug 28; 25(4):429-32. PubMed ID: 25254528 [Abstract] [Full Text] [Related]
13. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Talwalkar JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS. Gastroenterology; 2011 Nov 28; 141(5):1673-9. PubMed ID: 21723219 [Abstract] [Full Text] [Related]
15. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Austin MJ, McDougall NI, Wendon JA, Sizer E, Knisely AS, Rela M, Wilson C, Callender ME, O'Grady JG, Heneghan MA. Liver Transpl; 2008 Mar 28; 14(3):287-91. PubMed ID: 18306330 [Abstract] [Full Text] [Related]
16. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Liver Transpl; 2000 Jul 28; 6(4):443-50. PubMed ID: 10915166 [Abstract] [Full Text] [Related]